Biomarkers of protection against controlled human SARS-CoV-2 Delta variant breakthrough infection

Singanayagam A., Wagstaffe HR., Slater LJ., Fox-Sheehan P., Wu M-S., Mawer A., Scott H., Daly O., Low JM., Lopez Ramon R., Hughes E., Zhou J., Badhan A., Guy J., Harris S., Smith SP., Govender M., Laidlaw S., Tipton T., Satti I., Yaden M., Ascough SC., Sukhova K., Moshe M., McKenzie J., Siddiqui H., Ateere A., Francis B., Stiff F., Khoury D., Reynaldi A., Davenport M., Carroll M., Thwaites RS., Taylor GP., Barclay WS., Bracchi M., McShane H., Chiu C.

DOI

10.64898/2026.07.24.26358855

Type

Preprint

Publication Date

2026-07-30T00:00:00+00:00

Keywords

3207 Medical Microbiology, 32 Biomedical and Clinical Sciences, Infectious Diseases, Clinical Research, Biodefense, Coronaviruses Vaccines, Vaccine Related, Coronaviruses, Biotechnology, Immunization, Emerging Infectious Diseases, Prevention, Infection, Inflammatory and immune system

Permalink More information Close